Dr. Rosemarie Martin was recenly awarded $10.8 million for Opioid Treatment aimed at parolees and people on probation. The research award from the National Institutes of Health (NIH) was made to Brown University School of Public Health for research by Rosemarie Martin, Ph.D., and Damaris Rohsenow, Ph.D., along with Lauren Brinkley-Rubenstein, Ph.D., of University of North Carolina at Chapel Hill.

Drs. Mollie Monnig and Peter Monti have had an article titled Cerebral Metabolites on the Descending Limb of Acute Alcohol: A Premiliminary ¹H MRS, accepted for publication in Alcohol and Alcoholism. Their study examined metabolic changes in the brain on the descending limb of blood alcohol concentration. Congratulations to both!

Dr. Bernstein co-authored an article in BMJ-Evidence Based Medicine, led by Dr. Charlotte Blease at Harvard University. We critique the methodology of open-label placebo trials and argue that the quality of this research depends, in large part, upon the comparison condition. Dr. Blease presented this research, also co-authored by Dr. Cosima Locher (University of Plymouth), as an invited speaker at the Society for Interdisciplinary Placebo studies Conference in Leiden, Netherlands.

Dr. Jennifer Tidey was promoted to Deputy Editor of the journal Nicotine & Tobacco Research, for which she had been an Associate Editor since 2008.

Dr. Kahler provided an overview of how the Alcohol Research Center on HIV has been using scientific evidence to understand how counseling on heavy alcohol use can reduce the spread of HIV and improve the health of those living with HIV.

Dr. Patricia Cioe was nominated by her colleagues for the annual Excellence in Nursing Awards in the State of Rhode Island and was chosen as the Nurse Researcher of the Year! An article in the upcoming September issue of RI Monthly will highlight each of the winners and an awards reception to honor each of the recipients will be held in late September.

Dr. Carolina Haass-Koffler has received the American College of Neuropsychopharmacology (ACNP) Travel Award. The ACNP annually selects distinguished young scientists in the field of neuropsychopharmacology to be part of our travel award program. These travel awards offer an opportunity to attend an outstanding scientific program in clinical and basic research on brain-behavior-drug interactions.

Dr. Martin was a member of opening panel 'Inside Out – Exploring Cross Sector Collaboration for Maximum Impact' and breakout panel 'Leaning in-How criminal justice can integrate treatment, accelerate recovery and prevent arrests' at the National Opioid Leadership Summit in Sacramento June 24 - 25. The U.S. General Jerome Adams was the opening plenary speaker.